Author:
Kitahara Ken,Nakamura Yuji,Tsuneoka Yayoi,Adachi-Akahane Satomi,Tanaka Hikaru,Yamazaki Hiroshi,Takahara Akira,Yamazaki Junichi,Ikeda Takanori,Sugiyama Atsushi
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Toxicology,Molecular Biology
Reference18 articles.
1. Tullu, M. S. (2009). Oseltamivir. Journal of Postgraduate Medicine,
55, 225–230.
2. Dutkowski, R., Thakrar, B., Froehlich, E., Suter, P., Oo, C., & Ward, P. (2003). Safety and pharmacology of oseltamivir in clinical use. Drug Safety,
26, 787–801.
3. Wells, Q., Hardin, B., Raj, S. R., & Darbar, D. (2010). Sotalol-induced torsades de pointes precipitated during treatment with oseltamivir for H1N1 influenza. Heart Rhythm,
10, 1454–1457.
4. Hama, R. (2008). Fatal neuropsychiatric adverse reactions to oseltamivir: Case series and overview of causal relationships. The International Journal of Risk and Safety in Medicine,
20, 5–36.
5. Kimura, S., Niwa, Y., Iwajima, Y., Nagano, Y., Yamamoto, S., Ohi, Y., et al. (2012). High doses of oseltamivir phosphate induce acute respiratory arrest in anaesthetized rats. Basic & Clinical Pharmacology & Toxicology,
111, 232–239.
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献